SCHEMBL13868581

SCHEMBL13868581

CC1(C)OCC(C2OC(=O)C(OCCCO)=C2OCc2ccccc2)O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 1/20 0.39
TMEM97 Q5BJF2 2/20 0.35
SIGMAR1 Q99720 2/20 0.35
PRKCA P17252 1/20 0.34
LTA4H P09960 1/20 0.33
EPHX2 P34913 1/20 0.33
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
TP53 P04637 1/20 0.32
ACACB O00763 1/20 0.32
TBXA2R P21731 1/20 0.31
MAOB P27338 2/20 0.31
GRM2 Q14416 1/20 0.31
MYC P01106 1/20 0.31
HTR6 P50406 1/20 0.31
CTSV O60911 1/20 0.31
CTSL P07711 1/20 0.31
CTSB P07858 1/20 0.31
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8539003 0.90 TMEM97 (0.37) HPSETMEM97SIGMAR1OPRM1OPRD1
SCHEMBL13013398 0.90 TMEM97 (0.37) HPSETMEM97SIGMAR1OPRM1OPRD1
SCHEMBL10703049 0.90 TMEM97 (0.37) HPSETMEM97SIGMAR1OPRM1OPRD1
SCHEMBL6855778 0.89 HPSE (0.34) HPSETMEM97SIGMAR1PRKCAOPRM1
SCHEMBL16950173 0.85 TMEM97 (0.38) HPSETMEM97SIGMAR1PRKCAOPRM1
SCHEMBL6853632 0.85 TMEM97 (0.36) HPSETMEM97SIGMAR1OPRM1OPRD1
SCHEMBL8304197 0.85 PRKCA (0.32) PRKCA
SCHEMBL886854 0.84 TMEM97 (0.38) HPSETMEM97SIGMAR1PRKCAOPRM1
SCHEMBL6851717 0.84 TMEM97 (0.38) HPSETMEM97SIGMAR1PRKCAOPRM1
SCHEMBL17068318 0.82 TMEM97 (0.36) HPSETMEM97SIGMAR1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521477-B2 Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same PEPTRON CO., LTD. (KR) 2009-04-21 US disclosed
US-20070093425-A1 Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same PEPTRON CO., LTD. (KR) 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093425-A1 Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same PROC, CTRC, GC HPSE 3295/4885TMEM97 4180/4885SIGMAR1 4665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.